|Paul Edick||Chairman, Chief Executive Officer|
|Barry Deutsch||Chief Financial Officer|
|Allison Wey||Senior Vice President of Investor Relations & Corporate Communication|
|Zach Sachar||Piper Sandler|
|Daniel Busby||RBC Capital Markets|
Ladies and gentlemen, thank you for standing by and welcome to the Xeris Pharmaceuticals Second Quarter Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today’s conference is bring recorded.